Literature DB >> 35767161

Report on the ISMRM-ESMRMB 2022 hot topic debate on the future of gadolinium as a contrast agent.

Carlo Cosimo Quattrocchi1, Nivedita Agarwal2, Manuel Taso3, Ilona A Dekkers4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35767161     DOI: 10.1007/s10334-022-01024-4

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.533


× No keyword cloud information.
  1 in total

1.  Evaluation of gadolinium-157 as a neutron capture therapy agent.

Authors:  R M Brugger; J A Shih
Journal:  Strahlenther Onkol       Date:  1989 Feb-Mar       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.